Morgan Stanley’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1K | Buy |
29,452
+760
| +3% | +$519 | ﹤0.01% | 6648 |
|
|
2025
Q1 | $26.1K | Sell |
28,692
-1
| -0% | -$1 | ﹤0.01% | 6471 |
|
|
2024
Q4 | $31.3K | Sell |
28,693
-4,999
| -15% | -$5.45K | ﹤0.01% | 6431 |
|
|
2024
Q3 | $25.5K | Sell |
33,692
-87,307
| -72% | -$66.1K | ﹤0.01% | 6430 |
|
|
2024
Q2 | $150K | Sell |
120,999
-28,877
| -19% | -$35.8K | ﹤0.01% | 5797 |
|
|
2024
Q1 | $283K | Sell |
149,876
-179,536
| -55% | -$339K | ﹤0.01% | 5592 |
|
|
2023
Q4 | $870K | Buy |
329,412
+204,874
| +165% | +$541K | ﹤0.01% | 5365 |
|
|
2023
Q3 | $286K | Buy |
124,538
+18,725
| +18% | +$43.1K | ﹤0.01% | 5423 |
|
|
2023
Q2 | $386K | Buy |
105,813
+6,888
| +7% | +$25.1K | ﹤0.01% | 5345 |
|
|
2023
Q1 | $353K | Sell |
98,925
-79,871
| -45% | -$285K | ﹤0.01% | 5452 |
|
|
2022
Q4 | $510K | Sell |
178,796
-76,512
| -30% | -$218K | ﹤0.01% | 5243 |
|
|
2022
Q3 | $569K | Sell |
255,308
-180,274
| -41% | -$402K | ﹤0.01% | 5202 |
|
|
2022
Q2 | $1.09M | Buy |
435,582
+237,003
| +119% | +$590K | ﹤0.01% | 4962 |
|
|
2022
Q1 | $969K | Buy |
198,579
+21,760
| +12% | +$106K | ﹤0.01% | 5018 |
|
|
2021
Q4 | $2M | Sell |
176,819
-297,412
| -63% | -$3.36M | ﹤0.01% | 4582 |
|
|
2021
Q3 | $6.91M | Buy |
474,231
+46,876
| +11% | +$683K | ﹤0.01% | 3339 |
|
|
2021
Q2 | $4.98M | Buy |
427,355
+108,236
| +34% | +$1.26M | ﹤0.01% | 3780 |
|
|
2021
Q1 | $3.89M | Sell |
319,119
-224,943
| -41% | -$2.74M | ﹤0.01% | 3675 |
|
|
2020
Q4 | $6.81M | Buy |
544,062
+302,995
| +126% | +$3.79M | ﹤0.01% | 2928 |
|
|
2020
Q3 | $3.63M | Buy |
241,067
+103,360
| +75% | +$1.56M | ﹤0.01% | 3035 |
|
|
2020
Q2 | $3.38M | Buy |
137,707
+98,505
| +251% | +$2.41M | ﹤0.01% | 3072 |
|
|
2020
Q1 | $556K | Sell |
39,202
-36,826
| -48% | -$522K | ﹤0.01% | 4317 |
|
|
2019
Q4 | $1.21M | Buy |
76,028
+47,513
| +167% | +$754K | ﹤0.01% | 4402 |
|
|
2019
Q3 | $240K | Buy |
28,515
+6,789
| +31% | +$57.1K | ﹤0.01% | 5043 |
|
|
2019
Q2 | $196K | Buy |
21,726
+718
| +3% | +$6.48K | ﹤0.01% | 5031 |
|
|
2019
Q1 | $162K | Sell |
21,008
-27,529
| -57% | -$212K | ﹤0.01% | 5172 |
|
|
2018
Q4 | $228K | Sell |
48,537
-31,487
| -39% | -$148K | ﹤0.01% | 5228 |
|
|
2018
Q3 | $725K | Buy |
80,024
+39,212
| +96% | +$355K | ﹤0.01% | 4763 |
|
|
2018
Q2 | $484K | Buy |
40,812
+17,505
| +75% | +$208K | ﹤0.01% | 5122 |
|
|
2018
Q1 | $327K | Buy |
+23,307
| New | +$327K | ﹤0.01% | 5236 |
|